Veredus Laboratories
[May 1] As the cases of COVID-19 increase we are seeing a rise in digital epidemiology tools, chatbot helpers, EHR guidance tools and rapid-response test kits.
With the authorization by HSA, the VereCoV Detection Kit can be used directly by laboratories or hospitals to test patients for clinical diagnosis as an in-vitro diagnostic product (IVD).
According to a recent BT report, the VereCoV detection kit is expected to be commercially available by Feb 1 this year.